Sinopharm Group Co Ltd - Current Deferred Revenue
Sinopharm Group Co Ltd's Fiscal Year is From January To December - All Figures are in CNY, Billions.The Serie's long term average value is 8.10 Billion Chinese Yuans. It's latest available value, on 12/31/2023, is 180.35 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2014, to it's latest available value, on 12/31/2023, is +1,907.73%.
The Serie's change in percent from it's maximum value, on 12/31/2023, to it's latest available value, on 12/31/2023, is 0.0%.
Current Deferred Revenue for Related Companies:
| Logo | Name | Market Cap (USD) |
|---|---|---|
 | McKesson Corporation - Current Deferred Revenue | 100,579,704,832.00 |
 | Cencora Inc. - Current Deferred Revenue | 65,891,811,328.00 |
 | Cardinal Health Inc - Current Deferred Revenue | 47,241,023,488.00 |
 | Pop Mart International Group Ltd - Current Deferred Revenue | 32,494,046,097.69 |
 | BANDAI NAMCO Holdings Inc. - Current Deferred Revenue | 17,589,959,037.23 |